April 19 (SeeNews) - Serbian pharmaceuticals company Hemofarm has turned to a net profit of 2.8 billion dinars ($32.8 million/25.1 million euro) in 2012 from a net loss of 5.5 billion dinars a year earlier, data from the country's Business Registry Agency (APR) indicated.
about 1 hour agoabout 5 hours agoabout 22 hours agoabout 23 hours ago
about 1 hour agoabout 5 hours agoabout 22 hours agoabout 23 hours agoJun 10, 2026
BucharestJun 30, 2026Marrakech
